Skip to content

dr. Langlois Michel

Laboratoriumgeneeskunde
contactgegevens
01/01/2015
Endocrinologie

Bone scan alterations in aromatase inhibitor-treated patients.

Clin Nucl Med. 2015 Jan;40(1):38-40. doi: 10.1097/RLU.0000000000000588. PMID: 25290288dr. Van den Bruel Annickdr. De Cuypere Evelinedr. De Geeter Frankdr. Langlois Michel
01/01/2009
Endocrinologie

Spuriously high thyrotropin values due to anti-thyrotropin antibodies in adult patients.

Clin Chem Lab Med. 2009;47(5):604-6. PMID: 19397486dr. Van den Bruel Annickdr. Langlois Michel
01/01/2020
Laboratoriumgeneeskunde

The CCA Special Issue on Cardiovascular Markers.

Clin Chim Acta. 2020 [Editorial] doi: 10.1016/j.cca.2020.10.036dr. Langlois Michel
01/01/2020
Laboratoriumgeneeskunde

Update on current practice in laboratory medicine in respect of natriuretic peptide testing for heart failure diagnosis and management in Europe.

The CARdiac MArker Guideline Uptake in Europe (CARMAGUE) study. Clin Chim Acta 2020;511:59-66.dr. Langlois Michel
01/01/2020
Laboratoriumgeneeskunde

How well do laboratories adhere to recommended guidelines for dyslipidaemia management in Europe?

The CArdiac MARker Guideline Uptake in Europe (CAMARGUE) study. Chim Acta. 2020;508:267-272.dr. Langlois Michel
01/01/2020
Laboratoriumgeneeskunde

Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?

Curr Cardiol Rep. 2020;22:67.dr. Langlois Michel
01/01/2020
Laboratoriumgeneeskunde

Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM.

Atherosclerosis 2020;294:46-61.dr. Langlois Michel
01/01/2020
Laboratoriumgeneeskunde

Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM.

Clin Chem Lab Med. 2020;58:496-517.dr. Langlois Michel
01/01/2020
Laboratoriumgeneeskunde

Evolving concepts on the management of dyslipidaemia.

Acta Clin Belg – Int J Clin Lab Med 2020;75:80-90.dr. Langlois Michel
01/01/2020
Laboratoriumgeneeskunde

Investigations on the clinical utility of apolipoprotein B measurement: A research priority.

Eur J Prev Cardiol. 2020;27:1252–1254 [Editorial].dr. Langlois Michel
01/01/2020
Laboratoriumgeneeskunde

Muscle strength is a major determinant of the blood pressure response to isometric stress testing: the Asklepios population study.

J Hypertens 2020;38:224-234.dr. Langlois Michel
01/01/2019
Laboratoriumgeneeskunde

Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM.

Atherosclerosis 2020 doi: 10.1016/j.atherosclerosis.2019.12.005.dr. Langlois Michel
01/01/2019
Laboratoriumgeneeskunde

Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM.

Clin Chem Lab Med. 2019 doi: 10.1515/cclm-2019-1253.dr. Langlois Michel
01/01/2019
Laboratoriumgeneeskunde

Evolving concepts on the management of dyslipidaemia.

Acta Clin Belg – Int J Clin Lab Med 2019 https://doi.org/10.1080/17843286.2019.1702823dr. Langlois Michel
01/01/2020
Laboratoriumgeneeskunde

Muscle strength is a major determinant of the blood pressure response to isometric stress testing: the Asklepios population study.

J Hypertens 2020;38:224-234.dr. Langlois Michel
01/01/2019
Laboratoriumgeneeskunde

Investigations on the clinical utility of apolipoprotein B measurement: A research priority.

Eur J Prev Cardiol. 2019 doi: 10.1177/2047487319869578dr. Langlois Michel
01/01/2018
Laboratoriumgeneeskunde

Evaluation of four hemoglobin separation analyzers for hemoglobinopathy diagnosis.

J Clin Lab Anal. 2018;32:e22224.dr. Devos Helenadr. Emmerechts Jandr. Langlois Michel
01/01/2018
Laboratoriumgeneeskunde

Leukocyte telomere length and diet in the apparently healthy, middle-aged Asklepios population.

Sci Rep. 2018;8:6540.dr. Langlois Michel
01/01/2018
Laboratoriumgeneeskunde

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM.

Clin Chem. 2018;64:1006-1033.dr. Langlois Michel
01/01/2018
Laboratoriumgeneeskunde

The Role of Nutraceuticals in Statin Intolerant Patients.

J Am Coll Cardiol. 2018;72:96-118.dr. Langlois Michel
01/01/2018
Laboratoriumgeneeskunde

Which Lipids Should Be Analyzed for Diagnostic Workup and Follow-up of Patients with Hyperlipidemias?

Curr Cardiol Rep. 2018;20:88.dr. Langlois Michel
01/01/2018
Laboratoriumgeneeskunde

Overview of the current status of familial hypercholesterolaemia care in over 60 countries – The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).

Atherosclerosis. 2018;277:234-255.dr. Langlois Michel
01/01/2018
Laboratoriumgeneeskunde

A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy).

Atherosclerosis. 2018;277:369-376.dr. Langlois Michel
01/01/2018
Laboratoriumgeneeskunde

Evaluation of Four Hemoglobin Separation Analyzers for Hemoglobinopathy Diagnosis.

Journal of Clinical Lab Analysis 2018;32(1)dr. Devos Helenadr. Emmerechts Jandr. Langlois Michel
01/01/1970
Laboratoriumgeneeskunde

First EAS – EFLM consensus guideline on non-fasting lipid testing and reporting.

IFCC e-newsletter May-June 2016;20-21.dr. Langlois Michel
01/01/2016
Laboratoriumgeneeskunde

Lipidentesten op niet-nuchtere bloedafnames.

Eur Heart J 2016 en Clin Chem 2016 namens de Europese EAS/EFLM expertgroepdr. Langlois Michel
01/01/2016
Laboratoriumgeneeskunde

“Lipiden en lipoproteïnen” In: Wegwijs in Laboratoriumdiagnose.

Uitgeverij Acco 2016 p. 273-92. ISBN 978-94-6292-305-8.dr. Langlois Michel
01/01/2016
Laboratoriumgeneeskunde

Haptoglobin phenotype and Parkinson disease risk.

Parkinsonism Relat Disord. 2016;22:108-9.dr. Langlois Michel
01/01/2016
Laboratoriumgeneeskunde

Why are clinical practice guidelines not followed?

Clin Chem Lab Med. 2016;54:1133-9.dr. Langlois Michel
01/01/2016
Laboratoriumgeneeskunde

Fasting is not routinely required for determination of a lipid profile-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine.

Eur Heart J. 2016;37:1944-58dr. Langlois Michel
01/01/2016
Laboratoriumgeneeskunde

How Well Do Laboratories Adhere to Recommended Clinical Guidelines for the Management of Myocardial Infarction: The CARdiac MArker Guidelines Uptake in Europe Study (CARMAGUE).

Clin Chem. 2016;62:1264-71.dr. Langlois Michel
01/01/2016
Laboratoriumgeneeskunde

Could accreditation bodies facilitate the implementation of medical guidelines in laboratories?

Clin Chem Lab Med. 2016 [Epub ahead of print]dr. Langlois Michel
01/01/2015
Endocrinologie

Bone scan alterations in aromatase inhibitor-treated patients.

Clin Nuci Med. 2015 Jan;40(1):38-40.doi:10.1097/RLU.0000000000000588.dr. Van den Bruel Annickdr. De Geeter Frankdr. Langlois Michel
01/01/2013
Laboratoriumgeneeskunde

HDL-gerichte therapieën: behandeling van een risicofactor of make-up van een risicomerker?

ISBN 978-90-81054-26-3 Transmed Medical Communications 2013 pp. 29-46.dr. Langlois Michel
01/01/2013
Laboratoriumgeneeskunde

Serum amyloid A is independently related to apolipoprotein A-I but not to HDL-cholesterol in patients with angina pectoris Clin Biochem.

2013 [Epub ahead of print].dr. Langlois Michel
01/01/2013
Laboratoriumgeneeskunde

Genetic aspects of scurvy and the European famine of 1845-1848

Nutrients 2013; 5:3582-8.dr. Langlois Michel
01/01/2013
Laboratoriumgeneeskunde

Comparison of two immunoassays for measurement of faecal calprotectin in detection of Inflammatory Bowel Disease: (pre)-analytical and diagnostic performance characteristics.

Clin Chem Lab Med 2013 (in press).dr. Langlois Michel
01/01/2013
Laboratoriumgeneeskunde

Guideline from the European Atherosclerosis Society: clinical view on laboratory checklist and issues

Biochimica clinica 2013; 375(Suppl.):S36dr. Langlois Michel
01/01/2013
Laboratoriumgeneeskunde

Critical review of laboratory investigations in clinical practice guidelines: proposals for the description of investigation.

Clin Chem Lab Med. 2013; 51:1217-26.dr. Langlois Michel
01/01/2013
Laboratoriumgeneeskunde

Pseudonephritis is Associated With High Urinary Osmolality and High Specific Gravity in Adolescent Soccer Players.

Pediatr Exerc Sci. 2013; 25:360-9dr. Langlois Michel
01/01/2013
Laboratoriumgeneeskunde

Accuracy of three automated 25-hydroxyvitamin D assays in haemodialysis patients

Clin Chim Acta 2013; 415:255-60dr. Langlois Michel
01/01/2012
Laboratoriumgeneeskunde

Is it time to apply genographics in medical diagnosis?

Acta Clin Belgica 2012;67:387-8.dr. Langlois Michel
01/01/2012
Laboratoriumgeneeskunde

Human plasma protein polymorphisms and the persistence of cultural diversity.

Proc Natl Acad Sci U S A. 2012;109(43):E2914.dr. Langlois Michel
01/01/2012
Laboratoriumgeneeskunde

How I treat dyslipidemia according to the cardiovascular risk profile?

Rev Med Liège 2012; 67:167-173.dr. Langlois Michel
01/01/2012
Laboratoriumgeneeskunde

A genome-wide association study identifies rs2000999 as a strong genetic determinant of circulating haptoglobin levels

PLoS ONE 2012;7:e32327dr. Langlois Michel
01/01/2012
Laboratoriumgeneeskunde

Postanalytical opportunities of lipid and lipoprotein testing:laboratory approaches for predicting and managing risk of cardiovascular disease

Clin Chem Lab Med (invited article) 2012; 50:1169–1181.dr. Langlois Michel
01/01/2012
Laboratoriumgeneeskunde

The haptoglobin phenotype influences the risk of cutaneous squamous cell carcinoma in kidney transplant patients

J Eur Acad Dermatol Venereol 2012; 26:566-71.dr. Langlois Michel
Laboratoriumgeneeskunde

CASE REPORT: SPURIOUSLY HIGH VITAMIN A AND E LEVELS DUE TO HYPERLIPIDEMIA.

Virtual RBSLM Annual Meeting (Royal Belgian Society of Laboratory Medicine)dr. Langlois Michel
Laboratoriumgeneeskunde

Lipid testing in 2020.

Webinar CCA (Clin Chim Acta)dr. Langlois Michel
Laboratoriumgeneeskunde

Update on Dyslipidaemia Guidelines and the rationale of Cardiovascular Disease Biomarker.

Barcelonadr. Langlois Michel
Laboratoriumgeneeskunde

“Dyslipidemia- New clinical concepts and diagnostic tools”

Warschaudr. Langlois Michel
Laboratoriumgeneeskunde

Evaluation of Four Hemoglobin A1c Instruments.

Warschaudr. Langlois Michel
Laboratoriumgeneeskunde

“Non-fasting lipid profiles: implications for lipoprotein measurement and reporting”

EFLM e-seminardr. Langlois Michel
Laboratoriumgeneeskunde

LOK Cardiologie Richtlijnen en valkuilen bij het management van dyslipidemie

Bruggedr. Langlois Michel
Laboratoriumgeneeskunde

Euromedlab IFCC-EFLM Congress

Milaandr. Langlois Michel
Laboratoriumgeneeskunde

Comparison of two extraction devices for determination of faecal calprotectin on ImmunoCAP250

Milaandr. Langlois Michel
Laboratoriumgeneeskunde

Serum amyloid A is independently related to apolipoprotein A-I but not to HDL-cholesterol in patients with angina pectoris

Milaandr. Langlois Michel
Laboratoriumgeneeskunde

Accuracy of three automated 25-hydroxyvitamin D immunoassays compared to ID-XLC-MSMS in haemodialysis patients

Milaandr. Langlois Michel
Laboratoriumgeneeskunde

Accuracy of three automated immunoassays compared to ID-XLC-MSMS for the measurement of 25-hydroxyvitamin D in haemodialysis patients

Gentdr. Langlois Michel
Laboratoriumgeneeskunde

16éme Journée de Biologie Clinique

Brusseldr. Langlois Michel
Laboratoriumgeneeskunde

EliA™ CTD screen: enzyme fluoroimmunoassay for ANA detection

Granadadr. Hutsebaut Isabeldr. Langlois Micheldr. Roggeman Sylvie
Laboratoriumgeneeskunde

Symposium KBVKC, EAS Guidelines for dyslipidemia management

Groot-Bijgaardendr. Langlois Michel